Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Coping With Low Mortality and Exacerbation Rate Differences Between COPD Triple Therapy Studies, and a Proposal for Upcoming Studies
Alberto Ruano-Raviña; Alberto Fernández-Villar; José Luis López-Campos;
Arch Bronconeumol. 2020;56:336-8
Implicaciones clínicas del uso de la triple terapia en combinación de dosis fija en EPOC: del ensayo al paciente
José Luis López-Campos; Laura Carrasco-Hernández; Lucas Román Rodríguez; Esther Quintana-Gallego; Carmen Carmona Bernal; Bernardino Alcázar Navarrete;
Arch Bronconeumol. 2020;56:242-8
Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit
Myriam Calle Rubio; Marc Miravitlles; José Luis López-Campos; Bernardino Alcázar Navarrete; Juan José Soler Cataluña; Manuel E. Fuentes Ferrer; Juan Luis Rodríguez Hermosa;
Arch Bronconeumol. 2023;59:725-35